ArticleBiotechnology reports (Amsterdam, Netherlands)2023

Stable production of recombinant SARS-CoV-2 receptor-binding domain in mammalian cells with co-expression of a fluorescent reporter and its validation as antigenic target for COVID-19 serology testing.

Jorge L Arias-Arias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.